Produkty 118866-09-4

CAS 118866-09-4 występuje w naszej ofercie pod nazwami: (11Beta,17Z)-20-(Acetyloxy)-11-hydroxy-3-oxopregna-1,4,17(20)-trien-21-al, >95% (HPLC), (11b,17Z)-20-(Acetyloxy)-11-hydroxy-3-oxopregna-1,4,17(20)-trien-21-al, >95% (HPLC). Oferty producentów: TRC. Dostępne opakowania: 25mg, 50mg, 5mg.

(11Beta,17Z)-20-(Acetyloxy)-11-hydroxy-3-oxopregna-1,4,17(20)-trien-21-al, >95% (HPLC)
TRC
  • opakowanie: 25mg, 5mg
  • Warianty: 2
Zobacz produkt
(11b,17Z)-20-(Acetyloxy)-11-hydroxy-3-oxopregna-1,4,17(20)-trien-21-al, >95% (HPLC)
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(1Z)-1-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]-2-oxoethyl] acetate (CAS 118866-09-4) to związek chemiczny o wzorze sumarycznym C23H28O5 i masie molowej 384.5 g/mol. Nazwa systematyczna IUPAC: [(1Z)-1-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]-2-oxoethyl] acetate. InChIKey: XRKYIGLPYQFMMT-OJGNYEGDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H28O5
Masa molowa384.5 g/mol
Nazwa IUPAC[(1Z)-1-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]-2-oxoethyl] acetate
InChIKeyXRKYIGLPYQFMMT-OJGNYEGDSA-N
SMILESCC(=O)O/C(=C\1/CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)/C=O

Dane obliczone przez PubChem (NCBI)

Synonimy: (11?,17Z)-20-(Acetyloxy)-11-hydroxy-3-oxopregna-1,4,17(20)-trien-21-al, Budesonide Impurity 83, 20-(Acetyloxy)-11-hydroxy-3-oxopregna-1,4,17(20)-trien-21-al, (11beta,17Z)-, Pregna-1,4,17(20)-trien-21-al, 20-(acetyloxy)-11-hydroxy-3-oxo-, (11beta,17Z)-
Powiązane formy tego związku
[(1E)-1-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]-2-oxoethyl] acetate C23H28O5
Izomery (ten sam wzór sumaryczny)
[2-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O5
[2-[(8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O5
[2-[(8S,9S,10R,11R,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O5
(7R,8R,10S,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylic acid C23H28O5
(1R,4S,5R,8S,9R,10R,17S)-4,17-dimethylspiro[18-oxapentacyclo[8.7.2.01,9.04,8.012,17]nonadec-12-ene-5,5'-oxolane]-2',14,19-trione C23H28O5
[3-hydroxy-2-(4-phenylbutanoyloxy)propyl] 4-phenylbutanoate C23H28O5
[2-hydroxy-3-(4-phenylbutanoyloxy)propyl] 4-phenylbutanoate C23H28O5
[2-[(1S,2S,6S,7S,11S)-7,11-dimethyl-14-oxo-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadeca-9,15-dien-6-yl]-2-oxoethyl] acetate C23H28O5